Supernus Pharmaceuticals (SUPN) Announces Distribution from NEA

Supernus Pharmaceuticals (NASDAQ: SUPN) announced that it has received notice that, effective following the close of trading on December 3, 2015, New Enterprise Associates (NEA) distributed an aggregate of 3,820,625 shares of Supernus Pharmaceuticals common stock to its partners, and as a result no longer holds common stock in the company. "The distribution announced today is the third and final installment of a distribution that NEA initiated earlier this year and is consistent with its customary practices. NEA distributed shares of Supernus common stock to its limited partners after holding that position for over nine years," stated Jack Khattar, president and chief executive officer of Supernus.

You May Also Be Interested In

• BiomX announces 1-for-10 reverse stock split effective Sept. 9
• McCormick board member to resign after CFO appointment at Best Buy
• Nordson Corp. (NDSN) Raises Quarterly Dividend 14.6% to $0.94; 1.1% Yield